Literature DB >> 8243838

Impairment of bacterial flora in human ulcerative colitis and experimental colitis in the rat.

R Fabia1, A Ar'Rajab, M L Johansson, R Andersson, R Willén, B Jeppsson, G Molin, S Bengmark.   

Abstract

Changes in the colonic mucosa-associated microflora were determined both in patients with active and inactive ulcerative colitis and in rats with acetic acid-induced colitis. In patients with active ulcerative colitis, significant decreases in the number of anaerobic bacteria (Brain Heart Infusion medium), anaerobic gram-negatives and Lactobacillus were found, whereas no changes were seen in the number of aerobic bacteria and Enterobacteriaceae. In patients with inactive ulcerative colitis, no significant differences in colonic mucosa-associated microflora could be demonstrated. Similar changes were seen in rats with acetic acid-induced colitis. Thus, 4 days after acetic acid administration, at which time the colitis was well developed as evaluated by morphological appearance and myeloperoxidase activity, reduction in the number of anaerobic bacteria and Lactobacillus was seen. The first day after acetic acid administration, when the colitis had not developed, or after 14 days, when the colitis had been overcome, no alterations were seen in the mucosa-associated microflora as compared with control rats. We conclude that a reduction in the number of anaerobic bacteria and Lactobacillus is a common feature in active colitis regardless of the origin of colitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243838     DOI: 10.1159/000201045

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  30 in total

Review 1.  Bacteria as the cause of ulcerative colitis.

Authors:  M Campieri; P Gionchetti
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

2.  Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet.

Authors:  Mitsuro Chiba; Toru Abe; Hidehiko Tsuda; Takeshi Sugawara; Satoko Tsuda; Haruhiko Tozawa; Katsuhiko Fujiwara; Hideo Imai
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

Review 3.  Probiotics and inflammatory bowel diseases.

Authors:  A-P Bai; Q Ouyang
Journal:  Postgrad Med J       Date:  2006-06       Impact factor: 2.401

Review 4.  Bacteria in the intestine, helpful residents or enemies from within?

Authors:  Geraldine O Canny; Beth A McCormick
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

5.  Changes of colonic mucosal microcirculation and histology in two colitis models: an experimental study using intravital microscopy and a new histological scoring system.

Authors:  M Kruschewski; T Foitzik; A Perez-Cantó; A Hübotter; H J Buhr
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

6.  Differences in the reducing power along the rat GI tract: lower antioxidant capacity of the colon.

Authors:  S Blau; A Rubinstein; P Bass; C Singaram; R Kohen
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

Review 7.  Probiotics and medical nutrition therapy.

Authors:  Amy C Brown; Ana Valiere
Journal:  Nutr Clin Care       Date:  2004 Apr-Jun

8.  Bacteria and bacterial rRNA genes associated with the development of colitis in IL-10(-/-) mice.

Authors:  Jingxiao Ye; Jimmy W Lee; Laura L Presley; Elizabeth Bent; Bo Wei; Jonathan Braun; Neal L Schiller; Daniel S Straus; James Borneman
Journal:  Inflamm Bowel Dis       Date:  2008-08       Impact factor: 5.325

9.  Disease-dependent adhesion of lactic acid bacteria to the human intestinal mucosa.

Authors:  Arthur C Ouwehand; Seppo Salminen; Peter J Roberts; Jari Ovaska; Eeva Salminen
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

10.  Biologic targeting in the treatment of inflammatory bowel diseases.

Authors:  Matteo Bosani; Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.